SCHEMBL6950173

SCHEMBL6950173

CCNS(=O)(=O)c1ccc(N2N=C(C)/C(=C\Nc3ccccc3CC)C2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KAT8 Q9H7Z6 3/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
ALDH1A1 P00352 6/20 0.40
KDM4E B2RXH2 1/20 0.39
PTGS2 P35354 4/20 0.39
MAPT P10636 7/20 0.38
MAPK1 P28482 6/20 0.38
L3MBTL1 Q9Y468 6/20 0.38
KMT2A Q03164 6/20 0.38
MEN1 O00255 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TDP1 Q9NUW8 3/20 0.38
HTT P42858 2/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950175 1.00 KAT8 (0.42) KAT8CA1CA2CA9ALDH1A1
SCHEMBL8427562 0.95 KAT8 (0.41) KAT8CA1CA2CA9ALDH1A1
SCHEMBL8427563 0.95 KAT8 (0.41) KAT8CA1CA2CA9ALDH1A1
SCHEMBL6951766 0.87 PTGS2 (0.47) KAT8CA1CA2CA9ALDH1A1
SCHEMBL8009451 0.87 PTGS2 (0.47) KAT8CA1CA2CA9ALDH1A1
SCHEMBL6947265 0.85 KAT8 (0.42) KAT8CA1CA2CA9ALDH1A1
SCHEMBL6947262 0.85 KAT8 (0.42) KAT8CA1CA2CA9ALDH1A1
SCHEMBL6951498 0.83 L3MBTL1 (0.54) ALDH1A1KDM4EMAPTMAPK1L3MBTL1
SCHEMBL6951495 0.83 L3MBTL1 (0.54) ALDH1A1KDM4EMAPTMAPK1L3MBTL1
SCHEMBL8428159 0.82 PTGS2 (0.46) KAT8CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed